The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study
Hepatology2016Vol. 64(6), pp. 2077–2088
Citations Over TimeTop 1% of 2016 papers
Gonzalo Sapisochín, Nicolás Goldaracena, Jerome Laurence, Martin J. Dib, Andrew S. Barbas, Anand Ghanekar, Sean P. Cleary, Les Lilly, Mark S. Cattral, Max Marquez, Markus Selzner, Eberhard L. Renner, Nazia Selzner, Ian D. McGilvray, Paul D. Greig, David Grant
Abstract
Tumor differentiation and cancer-related symptoms of HCC can be used to select patients with advanced HCC who are appropriate candidates for liver transplantation; alpha-fetoprotein level limitations should be incorporated in the listing criteria for patients within or beyond the Milan criteria. (Hepatology 2016;64:2077-2088).
Related Papers
- → Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation(2015)126 cited
- → Hepatocellular carcinoma – time to take the ticket(2019)14 cited
- → Outcomes of Patients With Hepatocellular Carcinoma After Liver Transplant.(2015)3 cited
- [Living donor liver transplantation for the patient with hepatocellular carcinoma].(2004)